Effects of nonspecific β-adrenergic stimulation and blockade on blood coagulation in hypertension

Journal of Applied Physiology

Volumn 94, Issue 4, 2003, Pages 1455-1459

  Von Känel, Roland ^a,b,c   Dimsdale, Joel E ^a   Adler, Karen A ^a   Dillon, Elaine ^a   Perez, Christy J ^a   Mills, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ETH ZURICH   (Switzerland)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Hemostasis; Isoproterenol; Sympathetic nervous system; Von Willebrand factor

Indexed keywords

D DIMER; FIBRIN; ISOPRENALINE; PLACEBO; PROPRANOLOL; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BETA ADRENERGIC STIMULATION; BLOOD CLOTTING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INFUSION; ENDOTHELIUM CELL; FEMALE; FIBRIN FORMATION; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS;

EID: 0037379209     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00892.2002     Document Type: Article

References (36)

1. Blann AD, Naqvi T, Waite M, and McCollum CN. Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 7: 107-111, 1993.
2. Chandler WA, Levy WC, and Stratton JR. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during infusion of isoproterenol and phenylepinephrine. Circulation 92: 2984-2994, 1995.
3. Davies MJ. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res 82: 1-82, 1996.
4. Falkner B. Blood pressure response to mental stress. Am J Hypertens 4: S621-S623, 1991.
5. Galdal KS. Thromboplastin synthesis in endothelial cells. Haemostasis 14: 378-385, 1984.
6. Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 5: 86-99, 1983.
7. Julius S. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension. Eur Heart J 19, Suppl F: F14-F18, 1998.
8. Julius S and Majahalme S. The changing face of sympathetic overactivity inhypertension. Ann Med 32: 365-370, 2000.
9. Kendall MJ. Clinical trial data on the cardioprotective effects of β-blockade. Basic Res Cardiol 95, Suppl 1: 125-130, 2000.
10. Krantz DS and Manuck SB. Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique. Psychol Bull 96: 435-464, 1984.
11. Lande K, Kjeldsen SE, Os I, Westheim A, Hjermann I, Eide I, and Gjesdal K. Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension. J Hypertens 6: 219-225, 1988.
12. Lande K, Os I, Kjeldsen SE, Westheim A, Aakesson I, Hjermann I, Eide I, and Gjesdal K. Platelet volume, platelet release reaction and platelet response to infused adrenaline are increased in essential hypertension. Acta Med Scand Suppl 714: 129-132, 1986.
13. Larsson PT, Wallen NH, Martinsson A, Egberg N, and Hjemdahl P. Significance of platelet β-adrenoceptors for platelet responses in vivo and in vitro. Thromb Haemost 68: 687-693, 1992.
14. Lip GY and Blann AD. Von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J 74: 580-583, 1995.
15. Lip GY and Blann AD. Does hypertension confer a prothrombotic state? Virchow's triad revisited. Circulation 101: 218-220, 2000.
16. Lip GY and Lowe GD. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci (Colch) 89: 205-214, 1995.
17. Manuck SB, Kaplan JR, Adams MR, and Clarkson TB. Effects of stress and the sympathetic nervous system on coronary artery atherosclerosis in the cynomolgusmacaque. AmHeart J 116: 328-333, 1988.
18. Meyer D and Girma JP. Von Willebrand factor: structure and function. Thromb Haemost 70: 99-104, 1993.
19. Michel M, Brodde OE, and Insel P. Peripheral adrenergic receptors in hypertension. Hypertension 16: 107-120, 1990.
20. Miller MA, Spillert CR, Ponnudurai R, Bonthu S, and Lazaro EJ. Are hypertensives hypercoagulable? J Natl Med Assoc 87: 71-72, 1995.
21. Osterud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coagul Fibrinolysis 6, Suppl 1: S20-S25, 1995.
22. Osterud B. A global view on the role of monocytes and platelets in atherogenesis. Thromb Res 85: 1-22, 1997.
23. Palermo A, Bertalero P, Pizza N, Amelotti R, and Libretti A. Decreased fibrinolytic response to adrenergic stimulation in hypertensive patients. J Hypertens Suppl 7: S162-S163, 1989.
24. Pizzo SV and Pasqua JJ. The clearance of human fibrinogen fragments D1, D2, D3 and fibrin fragment D1 dimer in mice. Biochim Biophys Acta 718: 177-184, 1982.
25. Rapaport SI and Rao LV. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 12: 1111-1121, 1992.
26. Saab PG, Llabre MM, Ma M, DiLillo V, McCalla JR, Fernander-Scott A, Copen R, Gellman M, and Schneiderman N. Cardiovascular responsivity to stress in adolescents with and without persistently elevated blood pressure. J Hypertens 19: 21-27, 2001.
27. Short PE, Williams CE, Picken AM, and Hill FG. Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci 39: 351-355, 1982.
28. Tomoda F, Takata M, Kagitani S, Kinuno H, Yasumoto K, Tomita S, and Inoue H. Different platelet aggregability during mental stress in two stages of essential hypertension. Am J Hypertens 12: 1063-1070, 1999.
29. Tono-oka T, Nakayama M, Gotohda E, and Takeda T. Prevention of tissue factor generation in mononuclear cells by agents known to increase intracellular cyclic AMP. Tohoku J Exp Med 127: 161-167, 1979.
30. van Wersch JW, Rompelberg-Lahaye J, and Lustermans FA. Plasma concentration of coagulation and fibrinolysis factors and platelet function in hypertension. Eur J Clin Chem Clin Biochem 29: 375-379, 1991.
31. Vischer UM and Wollheim CB. Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signaling inexocytosis. Thromb Haemost 77: 1182-1188, 1997.
32. Von Kanel R and Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 65: 357-369, 2000.
33. Von Kanel R, Dimsdale JE, Ziegler MG, Mills PJ, Patterson TL, Lee SK, and Grant I. Effect of acute psychological stress on the hypercoagulable state in subjects (spousal caregivers of patients with Alzheimer's disease) with coronary or cerebrovascular disease and/or systemic hypertension. Am J Cardiol 87: 1405-1408, 2001.
34. Von Kanel R, Mills PJ, Fainman C, and Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 63: 531-544, 2001.
35. 2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 144: 68-72, 2002.
36. Wall RT, Counts RB, Harker LA, and Striker GE. Binding and release of factor VIII/von Willebrand's factor by human endothelial cells. Br J Haematol 46: 287-298, 1980.